Marinus Pharma: Q1 Earnings Insights

Marinus Pharma MRNS reported its Q1 earnings results on Thursday, May 11, 2023 at 07:01 AM.

Here's what investors need to know about the announcement.

Marinus Pharma beat estimated earnings by 6.94%, reporting an EPS of $-0.67 versus an estimate of $-0.72.

Revenue was down $3.81 million from the same period last year.

Last quarter the company missed on EPS by $0.06 which was followed by a 5.33% increase in the share price the next day.

Here's a look at Marinus Pharma's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.70	0.47	-0.68	-0.85
EPS Actual	-0.76	-0.94	-1.06	-0.52
Revenue Estimate	5.35M	29.48M	2.31M	2.28M
Revenue Actual	7.16M	2.34M	1.79M	14.19M

To track all earnings releases for Marinus Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar